Image For Activity Cover
Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial (JACC Heart Failure December 2022)

Hemodynamically-guided management using an implanted pulmonary artery pressure sensor is indicated to reduce heart failure (HF) hospitalizations in patients with New York Heart Association (NYHA) functional class II-III with a prior HF hospitalization or those with elevated natriuretic peptides.


JACC Heart Failure Editor-in-Chief
Biykem Bozkurt, MD, PhD, FACC 

Deputy Editor
Akshay S. Desai, MD, MPH 

JACC Heart Failure CME/MOC Editor
Kenneth A. Ellenbogen, MD

Michael H. Beasley, MD 

Important Dates

Date of Release: November 28, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: November 27, 2023

Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
Android App Download IOS App Download Powered By